Research on the innate immune response in transgenic mice following ischemic stroke

The high incidence, death, disability, and recurrence of ischemic stroke (CIS) place a significant cost on families and society. According to recent research on the condition, immune-related damage is a major contributor to the development and occurrence of CIS. Innate immunity and adaptive immunity...

Full description

Saved in:
Bibliographic Details
Main Authors: Chao Yuan, Yuting Shentu, Qiuhong Ji
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-11-01
Series:Frontiers in Aging Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2024.1476913/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846160527185674240
author Chao Yuan
Yuting Shentu
Qiuhong Ji
author_facet Chao Yuan
Yuting Shentu
Qiuhong Ji
author_sort Chao Yuan
collection DOAJ
description The high incidence, death, disability, and recurrence of ischemic stroke (CIS) place a significant cost on families and society. According to recent research on the condition, immune-related damage is a major contributor to the development and occurrence of CIS. Innate immunity and adaptive immunity are the two primary categories of the immune system in the body. The body’s first line of defense is innate immunity, and immune cells play a role in every stage of the immune system. At the same time, protein molecules play a vital function in regulating and differentiating immune cells. It can be said that protein molecules are the foundation of immune regulation. Model mice are necessary for us to examine fixed compounds in our studies. Conditional deletion and overexpression mouse models are the two primary categories of model mice. Numerous model mice have been documented in CIS research. The study of innate immune responses following ischemic stroke will benefit more from the use of these transgenic mice that target innate immunity. This paper analyzes the literature on transgenic mice related to innate immune responses following ischemic stroke because of the significance of these responses. It is anticipated to produce novel medications, improve clinical treatment guidance, and undergo a metamorphosis and application in the clinic in the future.
format Article
id doaj-art-2c92067e1cbc417fa746e5a7a76daf97
institution Kabale University
issn 1663-4365
language English
publishDate 2024-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Aging Neuroscience
spelling doaj-art-2c92067e1cbc417fa746e5a7a76daf972024-11-22T06:16:54ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652024-11-011610.3389/fnagi.2024.14769131476913Research on the innate immune response in transgenic mice following ischemic strokeChao Yuan0Yuting Shentu1Qiuhong Ji2Department of Neurology, Nantong University, Nantong, ChinaDepartment of Neurology, Nantong University, Nantong, ChinaDepartment of Neurology, Affiliated Hospital of Nantong University, Nantong, ChinaThe high incidence, death, disability, and recurrence of ischemic stroke (CIS) place a significant cost on families and society. According to recent research on the condition, immune-related damage is a major contributor to the development and occurrence of CIS. Innate immunity and adaptive immunity are the two primary categories of the immune system in the body. The body’s first line of defense is innate immunity, and immune cells play a role in every stage of the immune system. At the same time, protein molecules play a vital function in regulating and differentiating immune cells. It can be said that protein molecules are the foundation of immune regulation. Model mice are necessary for us to examine fixed compounds in our studies. Conditional deletion and overexpression mouse models are the two primary categories of model mice. Numerous model mice have been documented in CIS research. The study of innate immune responses following ischemic stroke will benefit more from the use of these transgenic mice that target innate immunity. This paper analyzes the literature on transgenic mice related to innate immune responses following ischemic stroke because of the significance of these responses. It is anticipated to produce novel medications, improve clinical treatment guidance, and undergo a metamorphosis and application in the clinic in the future.https://www.frontiersin.org/articles/10.3389/fnagi.2024.1476913/fullischemic stroketransgenic miceinnate immunitymicrogliamacrophages
spellingShingle Chao Yuan
Yuting Shentu
Qiuhong Ji
Research on the innate immune response in transgenic mice following ischemic stroke
Frontiers in Aging Neuroscience
ischemic stroke
transgenic mice
innate immunity
microglia
macrophages
title Research on the innate immune response in transgenic mice following ischemic stroke
title_full Research on the innate immune response in transgenic mice following ischemic stroke
title_fullStr Research on the innate immune response in transgenic mice following ischemic stroke
title_full_unstemmed Research on the innate immune response in transgenic mice following ischemic stroke
title_short Research on the innate immune response in transgenic mice following ischemic stroke
title_sort research on the innate immune response in transgenic mice following ischemic stroke
topic ischemic stroke
transgenic mice
innate immunity
microglia
macrophages
url https://www.frontiersin.org/articles/10.3389/fnagi.2024.1476913/full
work_keys_str_mv AT chaoyuan researchontheinnateimmuneresponseintransgenicmicefollowingischemicstroke
AT yutingshentu researchontheinnateimmuneresponseintransgenicmicefollowingischemicstroke
AT qiuhongji researchontheinnateimmuneresponseintransgenicmicefollowingischemicstroke